OX
Oxford BioDynamics Plc
OXBOF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £2.52M
P/E Ratio -
Div. Yield -
ROE 304.26%
Piotroski F-Score Weak
3/9Valuation
76 /100
Cheap P/B 2.26x
P/S 2.30x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 24.45%
Rev. growth 92.29%
FCF growth N/A
Profitability
19 /100
Weak Net margin 1,018.54%
Op. margin 1,011.32%
FCF margin 713.88%
Quality
2 /100
Poor ROE 304.26%
ROA 137.93%
Asset turnover 0.14x
Debt
7 /100
High Current ratio 0.88x
Int. coverage -26.07x
Debt/Equity 4.58x
Stability
26 /100
Unstable Rev. volatility 108.14%
EPS volatility 45.66%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OXBOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Compton
Employees
51
Headquarters
Oxford
Prihajajoči dogodki
26 JAN.
Earnings
Upcoming earnings report